Welcome to the e-CCO Library!

P051: Chemokines CXCL17, CCL20, and the receptor CXCR5 are overexpressed in the colonic mucosa from patients with active ulcerative colitis: CXCL17 is a potential marker of histological remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Yamamoto-Furusho*1, E. Iturriaga-Goyon2, G. Fonseca-Camarillo1

Created: Friday, 22 February 2019, 9:49 AM
P051: DNA methylation signatures associated with pathogenesis Crohn's disease-related genes
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Moret Tatay1,2, E. Cerrillo1,3, E. Sáez-González1,3, D. Hervás4, M. Iborra1,2,3, J. Sandoval5, E. Busó6, L. Tortosa1,2, P. Nos1,2,3, B. Beltrán1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P051: IFNγ-macrophages could mediate EMT in Crohn’s disease through the WNT pathway
Year: 2022
Source: ECCO'22
Authors: Edo, M.M.(1);Macias-Ceja, D.C.(2);Bauset, C.(2);Lis-Lopez, L.(2);Coll, S.(2);Seco-Cervera, M.(3);Cosin-Roger, J.(3);Calatayud, S.(2);Barrachina, M.D.(2);Ortiz-Masiá, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P051: Immune phenotypes in acute severe ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Meringer, H.(1)*;Canales-Herrerias, P.(2);Jha, D.(2);Livanos, A.(2);Jougon, J.(2);Cossarini, F.(3);Tankelevich, M.(2);Kayal, M.(2);Colombel, J.F.(2);Mehandru, S.(2);
Created: Friday, 14 July 2023, 10:48 AM
P051: Lower incidence of herpes zoster in vedolizumab-treated vs. tofacitinib-treated patients with ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Caldera1*, K. Lasch2, T. Lissoos2, C. Cao2, F. Bhayat3

Created: Thursday, 21 February 2019, 9:14 AM
P051: Macrophages as a source of Notch Ligands in Crohn's disease: implications in fibrosis
Year: 2021
Source: ECCO'21 Virtual
Authors: Jorge, M.A.(1);Barrachina, M.D.(1);Bauset, C.(1);Gisbert-Ferrándiz, L.(1);Cosin-Roger, J.(2);Coll, S.(1);Calatayud, S.(1);López-Serrano, A.(3);Ortiz-Masiá, D.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P051: Use of digital technology to boost patient recruitment in inflammatory bowel disease clinical trials
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bouhnik Y.*1, Amiot A.2, Alexandre N.1, Attar A.1, Kondamudi P.K.3, Stéfanescu C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P052 Nuclear magnetic resonance metabolomic profiling of IBD patients under anti-TNF treatment. Are the pathways network deregulated?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Notararigo1, M. Martin-Pastor2, J.E. Dominguez Munoz3, M. Barreiro-de Acosta3

Created: Thursday, 30 January 2020, 10:12 AM
P052: Comparing T cell responses to food antigens in Inflammatory Bowel Disease patients and healthy donors
Year: 2022
Source: ECCO'22
Authors: Schiffer, A.(1);Tran, F.(4);Sievers, L.K.(2);Kümpers, J.(2);Hinrichsen, H.(3);Seegers, B.(3);Bergfeld, A.(2);Lessing, M.(2);Schreiber, S.(4);Bacher, P.(4);
Created: Friday, 11 February 2022, 3:52 PM
P052: Comprehensive proteomic profiling of stool from UC and CD patients reveals expected and novel mucosal pathobiology, enabling identification of candidate non-invasive biomarkers to monitor mucosal disease activity
Year: 2021
Source: ECCO'21 Virtual
Authors: Harder, B.(1);Casavant, E.(1);McBride, J.(1);Park, K.T.(2);Mathews, W.R.(1);Anania, V.G.(1);Lekkerkerker, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P052: Heat shock protein GP96 is essential for maintaining intestinal epithelial architecture by supporting its self-renewal capacity
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Häfliger1, M. Schwarzfischer1, M. Van de Sande1, R. Manzini1, C. Stanzel1, K. Atrott1, S. Lang1, M. Scharl1, M. Spalinger1

Created: Friday, 22 February 2019, 9:41 AM
P052: IL-12p70 as a potential driver of pathogenic IL-17+IFNγ+ mucosal memory TIGITneg T cells in a subgroup of severe CD patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Heredia, M.(1)*;Barendregt, D.M.H.(1);van den Bogaerdt, S.(1);Samsom, J.N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P052: Intestinal total bacteria concentration and translocation of bacteria in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Vrakas1, M. Gazouli*2, K. Mountzouris3, G. Michalopoulos1, G. Karamanolis4, G. Papatheodoridis5, C. Tzathas1

Created: Friday, 22 February 2019, 9:49 AM
P052: Protein biomarkers identify subclinical inflammation patterns in first-degree relatives of patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Vancamelbeke1*, V. Ballet2, N. Ardeshir Davani1, G. Van Assche1,2, M. Ferrante1,2, I. Cleynen3, S. Vermeire1,2

Created: Thursday, 21 February 2019, 9:14 AM
P052: The role of TDAG8 in intestinal inflammation
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tcymbarevich I.1, de Vallière C.*1, Spalinger M.1, Cosin-Roger J.1, Atrott K.1, Richards S.2, Seuwen K.2, Frey-Wagner I.1, Rogler G.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P053 3-Oxo-C12:2, a quorum sensing molecule from the human gut, exerts anti-inflammatory effects through a bitter taste receptor
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Coquant, D. Aguanno, A. Peyrottes, L. Brot, S. Thenet, J.P. Grill, L. De Sordi, P. Seksik

Created: Thursday, 30 January 2020, 10:12 AM
P053: Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H-S. Kim*1, H. Park1, Y. Eom1

Created: Friday, 22 February 2019, 9:41 AM
P053: Circulating non-classical monocytes are reduced in patients with active IBD but increase after vedolizumab: a role for α4β7 in myeloid cell recruitment to the inflamed intestine
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gordon H.*1, Hoti I.2, Lindsay J.O.1,3, Stagg A.2

Created: Wednesday, 20 February 2019, 10:36 AM
P053: Histological and immunohistochemical indicators of progression towards malignancy in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Popp*1, G. Micu1, M. Cioplea1, L. Sticlaru1, G. Pop1, B. Mateescu2, F. Staniceanu1, S. Zurac1, L. Nichita1

Created: Friday, 22 February 2019, 9:49 AM
P053: Impact of N- acyl-homoserine lactone 3-oxo-C12:2, a major quorum sensing molecule from gut microbiota, on intestinal epithelial barrier function
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Aguanno1, E. Quevrain2, E. Le Balc’h2, C. Landman2,3, L. Brot2, A. Peyrottes2,4, J.-M. Mallet4, A. Leturque1, P. Seksik2,3*, J.-P. Grill2, S. Thenet1,5

Created: Thursday, 21 February 2019, 9:14 AM